{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:48:56Z","timestamp":1780710536192,"version":"3.54.1"},"reference-count":45,"publisher":"Manuscript Technomedia LLP","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Pharma Investig"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/2230-973x.106996","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T01:36:47Z","timestamp":1360114607000},"page":"189","source":"Crossref","is-referenced-by-count":8,"title":["Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration"],"prefix":"10.5530","volume":"2","author":[{"given":"Kevin","family":"Garala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaydeep","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir","family":"Raval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Dharamsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3478","reference":[{"key":"key-10.4103\/2230-973X.106996-1","first-page":"45","volume-title":"Crystal habit and tableting behavior","author":"Rasenack","year":"2002","journal-title":"Int J Pharm"},{"key":"key-10.4103\/2230-973X.106996-2","first-page":"699","volume-title":"Modification of crystal habit and its role in dosage form performance","author":"Tiwari","year":"2001","journal-title":"Drug Dev Ind Pharm"},{"key":"key-10.4103\/2230-973X.106996-3","first-page":"232","volume-title":"Preparation and evaluation of directly compressible form of rifampicin and ibuprofen","author":"Joshi","year":"2003","journal-title":"Ind J Pharm Sci"},{"key":"key-10.4103\/2230-973X.106996-4","first-page":"674","volume-title":"Preparation and in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates","author":"Usha","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"key-10.4103\/2230-973X.106996-5","first-page":"4","volume-title":"Crystallo-co-agglomeration: A novel particle engineering technique","author":"Paradkar","year":"2010","journal-title":"Asian J Pharm","ISSN":"https:\/\/id.crossref.org\/issn\/0973-8398","issn-type":"print"},{"key":"key-10.4103\/2230-973X.106996-6","first-page":"279","volume-title":"Development of matrix controlled release beads by extrusion-spheronization techniques technology using a statistical screening design","author":"Gokonda","year":"1994","journal-title":"Drug Dev Ind Pharm"},{"key":"key-10.4103\/2230-973X.106996-7","first-page":"33","volume-title":"Preparation and evaluation of ibuprofen beads by melt solidification technique","author":"Paradkar","year":"2003","journal-title":"Int J Pharm"},{"key":"key-10.4103\/2230-973X.106996-8","first-page":"155","volume-title":"Evaluation of melt agglomeration properties of polyethylene glycols using a mixer torque rheometer","author":"Johansen","year":"1999","journal-title":"Int J Pharm"},{"key":"key-10.4103\/2230-973X.106996-9","first-page":"191","volume-title":"A melt extrusion process for manufacturing matrix drug delivery systems","author":"Sprockel","year":"1997","journal-title":"Int J Pharm"},{"key":"key-10.4103\/2230-973X.106996-10","first-page":"1837","volume-title":"Direct agglomeration of sodium theophylline crystals produced by salting out in liquid","author":"Kawashima","year":"1982","journal-title":"Chem Pharm Bull"},{"key":"key-10.4103\/2230-973X.106996-11","first-page":"1127","volume-title":"Spherical crystallization: Direct spherical agglomeration of salicylic acid during crystallization","author":"Kawashima","year":"1982","journal-title":"Science"},{"key":"key-10.4103\/2230-973X.106996-12","unstructured":"Kadam SS, Mahadik KR, Paradkar AR. A process for making agglomerates for use as or in a drug delivery system. Indian Patent 1997;183036."},{"key":"key-10.4103\/2230-973X.106996-13","first-page":"E55","volume-title":"Agglomeration of Ibuprofen with talc by novel crystallo-co-agglomeration technique","author":"Pawar","year":"2004","journal-title":"AAPS PharmSciTech"},{"key":"key-10.4103\/2230-973X.106996-14","first-page":"45","volume-title":"Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique","author":"Maghsoodi","year":"2008","journal-title":"Int J Pharm"},{"key":"key-10.4103\/2230-973X.106996-15","first-page":"E59","volume-title":"Design and evaluation of deformable talc agglomerates prepared by crystallo-coagglomeration technique for generating heterogeneous matrix","author":"Jadhav","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"key-10.4103\/2230-973X.106996-16","first-page":"E44","volume-title":"Crystallo-coagglomeration: A novel process to obtain ibuprofen-paracetamol agglomerates","author":"Pawar","year":"2004","journal-title":"AAPS PharmSciTech"},{"key":"key-10.4103\/2230-973X.106996-17","first-page":"61","volume-title":"Tailoring of ketoprofen particle morphology via novel crystallocoaglomeration technique to obtain direct compressible material","author":"Chavda","year":"2008","journal-title":"Asian J Pharm","ISSN":"https:\/\/id.crossref.org\/issn\/0973-8398","issn-type":"print"},{"key":"key-10.4103\/2230-973X.106996-18","first-page":"25","volume-title":"Effect of drug content and agglomerate size on tablet ability and drug release characteristics of bromhexine hydrochloride-talc agglomerates prepared by crystallo-co-agglomeration","author":"Jadhav","year":"2010","journal-title":"Acta Pharm"},{"key":"key-10.4103\/2230-973X.106996-19","first-page":"40","volume-title":"Particle design of aceclofenac-disintegrant agglomerates for direct compression by crystallo-co-agglomeration technique","author":"Sarfaraz","year":"2011","journal-title":"Asian J Pharm Tech"},{"key":"key-10.4103\/2230-973X.106996-20","unstructured":"Schwartz JC, Lecomte JM, Form of administration of racecadotril. US Patent 20090186084A1, 2009."},{"key":"key-10.4103\/2230-973X.106996-21","unstructured":"Martin A, Swarbrick J, Cammarata A. Physical pharmacy: Physical chemical principles in the pharmaceutical sciences. Bombay, India; Varghese Publishing House; 1991. p. 423-52."},{"key":"key-10.4103\/2230-973X.106996-22","doi-asserted-by":"crossref","unstructured":"Raval MK, Sorathiya KR, Chauhan NP, Patel JM, Parikh RK, Sheth NR. Influence of polymers\/excipients on development of agglomerated crystals of secnidazole by crystallo-co-agglomeration technique to improve processability. Drug Dev Ind Pharm 2012 [Epub ahead of print].","DOI":"10.3109\/03639045.2012.662508"},{"key":"key-10.4103\/2230-973X.106996-23","first-page":"530","volume-title":"Comparison of granule strength and tablet tensile strength","author":"Jaroz","year":"1983","journal-title":"J Pharm Sci"},{"key":"key-10.4103\/2230-973X.106996-24","doi-asserted-by":"crossref","unstructured":"Gold GR. Devall N, Palermo BT, Slater JG. Powder flow studies II. Effect of glidants on flow rate and angle of repose. J Pharm Sci 1966;55:1291-5.","DOI":"10.1002\/jps.2600551125"},{"key":"key-10.4103\/2230-973X.106996-25","first-page":"127","volume-title":"Some aspects of the property of angle of repose of powders","author":"Train","year":"1958","journal-title":"J Pharm Pharmacol"},{"key":"key-10.4103\/2230-973X.106996-26","doi-asserted-by":"crossref","unstructured":"Jallo LJ, Ghoroi C, Gurumurthy L, Patel U, Dave RN. Improvement of flow and bulk density of pharmaceutical powders using surface modification, Int J Pharm 2012;423:213-25.","DOI":"10.1016\/j.ijpharm.2011.12.012"},{"key":"key-10.4103\/2230-973X.106996-27","first-page":"705","volume-title":"The flow properties of magnesia","author":"Pilpel","year":"1964","journal-title":"J Pharm Pharmacol"},{"key":"key-10.4103\/2230-973X.106996-28","first-page":"163","volume-title":"Evaluating flow properties of solids","author":"Carr","year":"1965","journal-title":"Chem Eng"},{"key":"key-10.4103\/2230-973X.106996-29","first-page":"301","volume-title":"Note on the measurement of flowability according to the European Pharmacopoeia","author":"Sch\u00fcssele","year":"2003","journal-title":"Int J Pharm"},{"key":"key-10.4103\/2230-973X.106996-30","first-page":"7","volume-title":"Friction conditions in a mass of metal powder","author":"Hausner","year":"1967","journal-title":"Int J Powder Metall"},{"key":"key-10.4103\/2230-973X.106996-31","first-page":"1364","volume-title":"A comparison of equations for powder compression","author":"Kawakita","year":"1966","journal-title":"Bull Chem Soc Jpn"},{"key":"key-10.4103\/2230-973X.106996-32","first-page":"1053","volume-title":"A particle rearrangement index based on the Kawakita powder compression equation","author":"Nordstrom","year":"2009","journal-title":"J Pharm Sci"},{"key":"key-10.4103\/2230-973X.106996-33","unstructured":"Kuno H. Funtai (powder theory and application). In: Iinoya K, Beddow JK, Jimbo G, editor. Tokyo: Maruzen; 1979. p. 342."},{"key":"key-10.4103\/2230-973X.106996-34","first-page":"1","volume-title":"Study of particle rearrangement, compression behavior and dissolution properties after melt dispersion of ibuprofen, Avicel and Aerosil","author":"Mallick","year":"2011","journal-title":"Results Pharma Sci"},{"key":"key-10.4103\/2230-973X.106996-35","first-page":"1001","volume-title":"An analysis of powder compaction phenomena","author":"Heckel","year":"1961","journal-title":"Trans Mettall Soc AIME"},{"key":"key-10.4103\/2230-973X.106996-36","first-page":"287","volume-title":"Elastic recovery and surface area changes in compacted powder systems","author":"Armstrong","year":"1974","journal-title":"Powder Technol"},{"key":"key-10.4103\/2230-973X.106996-37","first-page":"273","volume-title":"Influence of crosslinking agent on the release of drug from the matrix transdermal patches of HPMC\/Eudragit RL 100 polymer blends","author":"Garala","year":"2010","journal-title":"J Macromolecular Sci Part A"},{"key":"key-10.4103\/2230-973X.106996-38","first-page":"559","volume-title":"Spherical crystallization of mebendazole to improve processability","author":"Kumar","year":"2008","journal-title":"Pharm Dev Technol"},{"key":"key-10.4103\/2230-973X.106996-39","first-page":"476","volume-title":"Comparative tabletting behavior of Carbamazepine granules with spherical agglomerated crystals prepared by spherical crystallization technique","author":"Yadav","year":"2009","journal-title":"Int J Chem Tech Res"},{"key":"key-10.4103\/2230-973X.106996-40","first-page":"165","volume-title":"Development of directly compressible metformin hydrochloride by the spray-drying technique","author":"Barot","year":"2010","journal-title":"Acta Pharm"},{"key":"key-10.4103\/2230-973X.106996-41","first-page":"151","volume-title":"Improvement in flowability and compressibility of pharmaceutical crystals for direct tabletting by spherical crystallization with a two solvent system","author":"Kawashima","year":"1994","journal-title":"Powder Technol"},{"key":"key-10.4103\/2230-973X.106996-42","first-page":"6","volume-title":"A systematic study on micromeritic properties and consolidation behaviour of Terminalia Arjuna bark powder for processing into tablet dosage form","author":"Patra","year":"2007","journal-title":"Int J Pharma Exp"},{"key":"key-10.4103\/2230-973X.106996-43","first-page":"283","volume-title":"Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tabletting designed by spherical crystallization process","author":"Kawashima","year":"2003","journal-title":"Powder Technol"},{"key":"key-10.4103\/2230-973X.106996-44","unstructured":"US Department of Health and Human Services, Food And Drug Administration, Centre for Drug Evaluation and Research (1997). Guidance for Industry: Dissolution Testing of Immediate Release Solid Dosage Forms. Available from: http:\/\/www.fda.gov\/Drugs\/Guidance compliance Regulatory Information\/Guidance\/ucm070 246.pdf [Last accessed on 2011 Jun 19]."},{"key":"key-10.4103\/2230-973X.106996-45","unstructured":"EMEA: Committee for Proprietary Products, London, UK (1999). Note for Guidance on Quality of Modified Release Product: A Oral Dosage form. Available from: http:\/\/www.ema.europa.eu\/pdfs\/human\/qwp\/060496en.pdf. [Last accessed on 2011 Jun 19]."}],"container-title":["International Journal of Pharmaceutical Investigation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:09:51Z","timestamp":1771578591000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpionline.org\/article\/2\/4\/189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"alternative-id":["106996"],"URL":"https:\/\/doi.org\/10.4103\/2230-973x.106996","relation":{},"ISSN":["2230-973X"],"issn-type":[{"value":"2230-973X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}